Legal Issues Surround Using Artificial Intergenic and Leukocyte Epigenomics To Evaluate and Predict Late-Onset Alzheimer’s Disease
Leukocyte epigenomics and artificial intergenic are used to assess and predict late-onset Alzheimer’s disease. It is a complicated topic that poses various legal issues. Artificial intelligence is an emerging technology that is transforming the medical sector. It offers multiple services, including disease diagnosis, prognosis, and individualized therapies (Bahado-Singh et al., 2021). Yet, this technology also poses ... Read More
Pages: 16 Words: 4130